市場調査レポート
商品コード
1073701
臨床試験管理システム(CTMS)の世界市場規模:展開別、デリバリー別、製品・サービス別、エンドユーザー別、地域別の予測(2022年~2028年)Global Clinical Trial Management System Market Size study, By Deployment, By Delivery, Licensed Enterprise ), Cloud-based ), By Product & Service, By End-User, and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
臨床試験管理システム(CTMS)の世界市場規模:展開別、デリバリー別、製品・サービス別、エンドユーザー別、地域別の予測(2022年~2028年) |
出版日: 2022年04月30日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界の臨床試験管理システム(CTMS)の市場規模は、2021年に約8億100万米ドルとなり、2022年~2028年の予測期間中に14.7%を超える健全な成長率で成長すると予想されています。
市場成長の主な要因は、臨床試験数の増加、政府からの資金提供の増加、臨床試験をサポートするための助成金、製薬・バイオ企業とCROの間の研究提携の増加です。一方で、熟練した専門家の不足が、2022年~2028年の予測期間における市場成長を妨げとなっています。Platform-as-a-Service(PaaS)やモバイルコンピューティングとの高い統合性は、予測期間中の市場需要を促進すると予想されます。
当レポートでは、世界の市場に臨床試験管理システム(CTMS)ついて調査分析し、市場動向、業界分析、COVID-19の影響、セグメント別・地域別の市場分析、企業プロファイルなどを提供しています。
List of figures
Global Clinical Trial Management System Market is valued at approximately USD 801 million (0.801 billion) in 2021 and is anticipated to grow with a healthy growth rate of more than 14.7% over the forecast period 2022-2028. The Clinical Trial Management System is a software system that is used to maintain and manage the planning, executing, and reporting functions as well as handle members' contact information and tracking deadlines. This system is gaining huge traction among the pharmaceutical and biotechnology industry to manage clinical trials during clinical research. The primary factors such as the rising number of clinical trials, growing government fundings, and grants to support clinical trials, coupled with increasing research partnerships between pharma-biopharma companies and CROs have led to the adoption of Clinical Trial Management System across the forecast period. For instance, in December 2020, ERT-a a leading global data and technology company declared the launch of Data Insights- the company's novel Trial Oversight solution that offers a more precise and rapid discovery of variabilities in endpoint data collection and management. Thereby, the growing availability of advanced CTMS solutions will further stimulate market growth across the globe. However, the lack of skilled professionals impedes the growth of the market over the forecast period of 2022-2028. Also, high integration with Platform-as-a-service (PaaS) and mobile computing is anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the Global Clinical Trial Management System Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the escalating demand for drug development, presence of leading pharmaceutical companies and CROs, and rising number of drug development activities. Whereas, Asia-Pacific is also anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the presence of large patient pool, increasing number of government fundings to support clinical trials, as well as low operating costs for conducting clinical trials would create lucrative growth prospects for the Clinical Trial Management System Market across the Asia-Pacific region.
Major market players included in this report are:
Bio-Optronics
Oracle Corporation
Advarra Technology Solutions
Parexel International
MasterControl
Crucial Data Solutions
DataStat
RealTime Software Solutions LLC
Medidata Solutions
DZS Clinical Services
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Deployment
Enterprise-wide CTMS
On-Site CTMS
By Delivery
Web-based (On-demand)
Licensed Enterprise (On-premises)
Cloud-based (SaaS)
By Product & Service
Software
Services
By End-User
Large Pharma-biotech Companies
CROs
Medical Device Manufacturers
Small & Mid-sized Pharma-biotech Companies
Other End-Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Clinical Trial Management System Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors